Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Vibholm LK, Konrad CV, Schleimann MH, Frattari G, et al. Effects of 24 Week Toll-Like Receptor 9 Agonist Treatment in HIV-1+ Individuals: a single-arm, phase 1B/2A trial. AIDS 2019 Mar 29. doi: 10.1097/QAD.0000000000002213.
PMID: 30932955


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016